These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2333308)

  • 1. [Chemical instability of the antipsoriatic dithranol and chrysarobin in aqueous systems: oxidation behavior].
    Berset JD; Krebs A
    Pharm Acta Helv; 1990; 65(3):66-9. PubMed ID: 2333308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The oxidation behavior of dithranol].
    Schaltegger A
    Arzneimittelforschung; 1985; 35(4):666-8. PubMed ID: 4015731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Stability of cignolin (dithranol) in ointments containing tar with and without the addition of salicylic acid. Oxidation to danthron and dithranol dimer].
    Müller R; Naumann E; Detmar M; Orfanos CE
    Hautarzt; 1987 Feb; 38(2):107-11. PubMed ID: 3570777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Silylation of dithranol and derivatives of its oxidation].
    Prognon P; Gond A; Dubertret L; Mahuzier G
    Ann Pharm Fr; 1982; 40(4):329-37. PubMed ID: 7158956
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxidation of antipsoriatic 10-acyldithranol derivatives and dithranol to 1,8-dihydroxyanthraquinone.
    Taskinen J; Haarala J; Wartiovaara E; Halmekoski J
    Arch Pharm (Weinheim); 1988 Feb; 321(2):103-6. PubMed ID: 3369924
    [No Abstract]   [Full Text] [Related]  

  • 6. Free radical intermediates produced by autoxidation of 1,8-dihydroxy-9-anthrone (dithranol) in pyridine.
    Martinmaa J; Vanhala L; Mustakallio KK
    Experientia; 1978 Jul; 34(7):872-3. PubMed ID: 208855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). I. Phase I clinical trial of 10-propionyl dithranol and 10-butyryl dithranol (butantrone).
    Mustakallio KK; Brandt H
    Acta Derm Venereol; 1984; 64(1):63-6. PubMed ID: 6203285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization of dithranol in topical formulations.
    Thoma K; Holzmann C
    Acta Pharm Hung; 1998 Nov; 68(6):313-21. PubMed ID: 9987194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anthralin: chemical instability and glucose-6-phosphate dehydrogenase inhibition.
    Cavey D; Caron JC; Shroot B
    J Pharm Sci; 1982 Sep; 71(9):980-3. PubMed ID: 7131282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermal absorption and metabolism of the antipsoriatic drug dithranol triacetate.
    Wiegrebe W; Retzow A; Plumier E; Ersoy N; Garbe A; Faro HP; Kunert R
    Arzneimittelforschung; 1984; 34(1):48-51. PubMed ID: 6538420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the stability of some antipsoriatic active anthralin (dithranol) derivatives.
    Schaltegger A; Bloch U; Krebs A
    Dermatologica; 1982 Oct; 165(4):363-8. PubMed ID: 7152072
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhanced stability of sulfamethoxazole and trimethoprim against oxidation using hydroxypropyl-beta-cyclodextrin.
    Pourmokhtar M; Jacobson GA
    Pharmazie; 2005 Nov; 60(11):837-9. PubMed ID: 16320945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of anthralin in dermatological products by reversed-phase high-performance liquid chromatography.
    Burton FW; Gadde RR
    J Chromatogr; 1985 Jun; 328():317-24. PubMed ID: 4030969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dithranol reaction with nitroxide radicals in DMSO, a HPLC study.
    Ferlan A; Pecar S; Schara M
    Pharmazie; 2003 Jul; 58(7):475-9. PubMed ID: 12889530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-pressure liquid chromatographic determination of anthralin in ointments.
    Caron JC; Shroot B
    J Pharm Sci; 1981 Nov; 70(11):1205-7. PubMed ID: 7299664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and characterization of 9-anthron-10-yl radicals formed by antipsoriatic and tumor-promoting 9-anthrones in aqueous buffers.
    Hayden PJ; Chignell CF
    Chem Res Toxicol; 1993; 6(2):231-7. PubMed ID: 8386561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dithranol: further investigations on the structure-activity-relationship. The new series of the 10-mono-alkyldithranol derivatives.
    Schaltegger A; Brunner F; Steiger W; Krebs A
    Dermatologica; 1987; 175(3):136-41. PubMed ID: 3653461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxyl radical formation by dithranol.
    Müller K; Kappus H
    Biochem Pharmacol; 1988 Nov; 37(22):4277-80. PubMed ID: 2848524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [10-Acyldithranol dimers; new derivatives of the antipsoriatic dithranol; synthesis, characterization and biochemical properties].
    Berset JD; Krebs A
    Pharm Acta Helv; 1990; 65(5-6):155-64. PubMed ID: 2371307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Purification, glucose-6-phosphate dehydrogenase inhibition, and HPLC analysis of four 1,8-dihydroxyanthrones].
    Rychener M; Steiger W
    Pharm Acta Helv; 1989; 64(1):8-15. PubMed ID: 2717648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.